tbuckley/cabot-search huggingface dataset:
Obesity and the evolution of man
Authors: A. Montagu
Journal: JAMA (1966)

Anyone who is familiar with the appearance of L monkeys and apes in zoos will have noted that occasionally some of these creatures tend to be obese. The orang-utan in captivity often tends to become strikingly obese—rather more so than any other ape. Chimpanzees may become well filled out in captivity, but seldom obese. Under natural conditions, there are two factors that militate against the development of obesity in nonhuman primates. The first is that, with the exception of man, all primates are predominantly herbivorous, and it is difficult to become obese on a plant diet. The second is that these creatures are very active, and thus get a great deal of exercise. These two factors, under natural conditions, tend to keep all primates adequately well-upholstered but not overstuffed. In captivity, confined within a limited space, monkeys and gibbons manage to maintain some activity, as the chimpanzee also sometimes does.
Decrease in Infant Mortality and Sudden Infant Death Syndrome Among Northwest American Indians and Alaskan Natives— Pacific Northwest, 1985-1996
Journal: JAMA (1999)

Although the infant mortality rate (IMR) has steadily declined in the United States since the early 1900s, the rate varies among racial/ethnic populations. A goal of the national health objectives for 2010 is to eliminate racial/ethnic health disparities (U.S. Department of Health and Human Services, unpublished data, 1999). Historically, IMRs among American Indians and Alaskan Natives (AI/AN) have been high. In addition, IMRs have varied among AI/AN populations. To determine recent trends in infant mortality among Northwest AI/AN, the Northwest Portland Area Indian Health Board (NPAIHB) analyzed annual IMRs among AI/AN in Idaho, Oregon, and Washington. In addition, because sudden infant death syndrome (SIDS) is the major contributor to excess infant mortality in Northwest AI/AN, NPAIHB analyzed SIDS rates to determine whether the decline in SIDS rates in the United States also was occurring among Northwest AI/AN. This report summarizes the results of this analysis and documents dramatic decreases in both SIDS and non-SIDS infant mortality.
Abstract 3263: Right Heart Findings on Supine Bicycle Stress Echocardiography are Highly Predictive of Severe Sleep Apnea in Women Presenting with Chest Pain and Shortness of Breath
Authors: Steven C Smart, Vicki McHugh, Michelle A Mathiason
Journal: Circulation (2007)

Background: Chest pain and shortness of breath may be multifactorial, especially in women, and not always indicative of ischemic heart disease. Sleep apnea may contribute to mortality and morbidity in ischemic heart and cerebral vascular patients. Supine bicycle echocardiography is an effective tool to evaluate right heart function at rest and with stress. Objective: To determine if right heart abnormalities driving supine bicycle stress echocardiography are predictive of hemodynamic significant sleep apnea. Methods: 638 consecutive women presenting with chest pain and/or shortness of breath underwent multistage supine bicycle stress echocardiography/Doppler imaging for left ventricular wall motion, ejection fraction (EF), right ventricular (RV) size and function, tricuspid (TR) and mitral (MR) regurgitation, and systolic pressure. Data was also collected on those who underwent sleep studies. ROC analysis was used to evaluate predictive value for severe sleep apnea (RDI ≥ 30). Results: Mean age was 63 ± 13 years, mean BMI 30 ± 7, and 80% post-menopausal. Mean EF was 62 ± 12%. Supine bicycle stress echocardiography/Doppler at peak exercise revealed moderate/severe RV enlargement 26%, RV hypokinesis 26%, and moderate/severe TR 40%. Mean values for exercise tolerance, peak heart rate, and peak systolic blood pressure were 4.3 ± 1.7 METs, 131 ± 23 bpm, and 183 ± 26 mmHg, respectively. Sleep study data was available for 88 women, of whom 45% had an RDI ≥ 30. 83% of sleep study subjects exhibited a combination of moderate/severe TR, moderate/severe RV dilatation, or moderate/severe hypokinetic RV function. The best predictor of severe sleep apnea was RV size ( C = 0.705) at peak exercise. RV function ( C = 0.640) and TR volume ( C = 0.603) at peak exercise were moderate predictors. Epworth score (10.4 ± 4.0; C = NA) or pulmonary pressure (77.5 ± 14.7 mmHg; C = 0.525) alone were only fair predictors. A model containing RV function, RV size, TR, and EF at peak exercise ( C = 0.730) further improved prediction of identification of those with severe sleep apnea. Conclusion: Sleep apnea can present with cardiopulmonary symptoms in advanced stages. Right heart abnormalities during supine bicycle stress echocardiography warrant screening for moderate/severe sleep apnea.
Response
Authors: R. A. DAYNARD
Journal: JNCI Journal of the National Cancer Institute (1988)

Journal Article Response Get access RICHARD A. DAYNARD RICHARD A. DAYNARD Northeastern University School of Law400 Huntington Avenue Boston, MA 02115 Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 80, Issue 7, 1 June 1988, Page 535, https://doi.org/10.1093/jnci/80.7.535 Published: 01 June 1988
Acute Folic Acid Deficiency of Unknown Etiology: Temperate Sprue
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Atheroma of the Coronary Arteries.
Journal: JAMA (1885)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Protection against endometrial carcinoma by combination-product oral contraceptives
Authors: B. S. Hulka
Journal: JAMA (1982)

Seventy-nine patients with endometrial carcinoma were compared with 203 control subjects regarding their use of combination-product oral contraceptives (OCs). Overall, 6.3% of patients and 15.3% of control subjects had used these products. The risk of endometrial cancer for users of OCs was less than half the risk for nonusers. Five years or more of use reduced the risk to a third. Recent users were strongly protected, whereas discontinuation resulted in risks returning to those of nonusers. Furthermore, OCs with predominantly progestational effects or intermediate formulations produced greater protection than those with predominantly estrogens. This pattern of results is biologically consistent with a protective effect of combination-product OCs against endometrial carcinoma. (<i>JAMA</i>1982;247:475-477)
Development of Atopy and Asthma: Candidate Environmental Influences and Important Periods of Exposure
Authors: David B. Peden
Journal: Environmental Health Perspectives (2000)

Atopy is a major risk factor for the development of asthma.Immune processes that lead to the development of antigen-specific IgE are essential to the development of atopy.This review examines the immune processes that are candidate targets for modulation by environmental agents; environmental and lifestyle factors that have been suggested as modulators of the development of atopy; and the impact of known environmental agents on atopic processes in the airway.The most important periods of immune development with regard to expression of atopy are likely during gestation and early childhood.A better understanding of which environmental agents are important, as well as the period of life during which these agents may exert an important effect, is essential to devising rational environmental avoidance strategies for at-risk populations.
Vesicoureteral reflux. An inherited lesion
Authors: J. D. Schmidt
Journal: JAMA (1972)

Vesicoureteral reflux in siblings or different generations has not been emphasized. In nine families, each with two members having unilateral or bilateral reflux, at least one member from each family has required surgical correction. Family surveys demonstrated other congenital and acquired urinary tract abnormalities. Failure of conservative management plus cystoscopic evidence of a defective ureteral orifice support a familial or hereditary basis for vesicoureteral reflux.
"Organic Food"
Authors: Minna Silverglade
Journal: JAMA (1975)

<h3>To the Editor.—</h3> I was glad to see the WHEN FRIENDS OR PATIENTS ASK ABOUT... section carry an article about "organic foods" (230:276, 1974). However, I feel a correction is due on one point. Dr. Jukes's report is misleading in giving the answer to question 5 as "true." While there is "no difference in food value" as far as<i>vitamin</i>content is concerned, there may be significant difference in<i>mineral</i>content, and this should be considered when listing food values. An example of mineral-content variation is found in the iodine content of foods grown in US "goiter belt" areas compared with the iodine value of foods from certain seacoast areas. Pennington and Calloway<sup>1</sup>discuss the difference in copper content found in foods grown in different soils. Other trace minerals in vegetables, cereals, and other foods can also be influenced by soil content. I share Dr. Jukes's concern over the dangers
FACTS AND THEORIES RELATING TO AUTOINTOXICATION.
Journal: JAMA (1899)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Summaries of Posters
Journal: British Journal of Dermatology (2003)

British Journal of DermatologyVolume 149, Issue s64 p. 83-85 Summaries of Posters First published: 03 October 2008 https://doi.org/10.1046/j.1365-2133.149.s64.61.xCitations: 1AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume149, Issues64July 2003Pages 83-85 RelatedInformation
Numeric Error in Key Points Findings
Journal: JAMA Network Open (2019)

In the Original Investigation titled "Antipsychotic Treatment Among Youths With Attention-Deficit/ Hyperactivity Disorder," 1 published on July 26, 2019, there was a numeric error in the Key Points Findings.The number given as "2.3%" should have been "2.6%."This article has been corrected.
Peripheral diabetic neuropathy treated with amitriptyline and fluphenazine
Authors: J. L. Davis
Journal: JAMA (1977)

The pain of diabetic peripheral neuropathy responds poorly to current modes of treatment. We treated eight patients with this disorder whose pain was refractory to standard regimens but who experienced remarkable pain relief within two to five days after treatment with fluphenazine hydrochloride, amitriptyline hydrochloride, or a combination of the two. In four patients whose regimens were discontinued, pain recurred within two days and again remitted on reinstitution of the drug regimens. These findings suggest that fluphenazine alone or in combination with amitriptyline may be of benefit in treating the painful peripheral neuropathy associated with diabetes. (<i>JAMA</i>238:2291-2292, 1977)
DIFFUSE PAPILLOMATOUS GROWTHS IN THE URINARY PASSAGES.
Journal: JAMA (1901)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Contract Practice and Ethics.
Journal: JAMA (1883)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Can the intensive care unit be harmful?
Authors: D. H. Spodick
Journal: JAMA (1983)

<h3>To the Editor.—</h3> Dr Knaus' editorial (1983;249:1059) covering uncertainties about the impact of intensive care units (ICUs) hits the target squarely—"not a single scientific study claiming that, by itself, intensive care unit support cures any disease." He reasonably suggests an approach by "rigorous selective study of acutely ill patients, through the prospective identification of important physiological indicators." Beyond this, however, not a single scientific study has investigated whether ICU support actually harms some patients, since it is clear that invasive instrumentation per se has this potential.<sup>1</sup> In essence, Dr Knaus appropriately considers the ICU itself to be a form of treatment. I think his objectives, shared by all of us—essentially determination of risk-benefit ratios—can best be approached by the most scientific and ethical method of getting an answer about any kind of treatment: a prospective randomized, controlled therapeutic trial.<sup>2</sup>One method for doing this would be to have
February 25, 2003
Authors: James T. Willerson
Journal: Circulation (2003)

is the Section Editor for Circulation's newest section, Mini-Reviews: Expert Opinions.Expert opinions and advice will be solicited from internationally recognized thought-leaders for topics in cardiovascular medicine that are of interest to the cardiovascular clinician.In addition, health-care policy and patient care issues will be examined attempting to improve clinical care and resource utilization.Mini-Reviews:
INTERNATIONAL UNIFICATION OF MEDICAL STATISTICS.
Journal: JAMA (1904)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
HIV Infection, Pregnant Women, and Newborns
Journal: JAMA (1990)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Errata
Journal: Circulation Research (1959)

In the Editorial in Circulation Research for July, 1959, the first paragraph on page 509 contains two errors: SCHMIDT, C. F.: Editorial: Cardiac response to exercise. Circulation Research 7: 507, 1959. page 509: line 13 should read"... a corresponding rise in arterial pCO 2 and fall in pH ..." lines 28-29 should read: "Fall in arterial pO 2 probably is not a factor ..." (not pCO 2 as published).
Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region
Authors: M. Robert-Guroff
Journal: JAMA (1986)

Antibody prevalences for human T-cell lymphotropic virus (HTLV) types I, II, and III were determined for 56 intravenous drug abusers from Queens, NY. While control serum samples lacked antibodies to all HTLV subgroups, seropositivity among drug users was 41% for HTLV-III, 18% for HTLV-II, and 9% for HTLV-I. Infection by HTLV-I and -II occurred independently of HTLV-III infection. Blacks had greater HTLV-III antibody prevalence than whites (54% vs 16%) and were more likely than whites to be seropositive for HTLV-I or -II (46% vs 11%). They exhibited a greater incidence than whites of double infection with HTLV-I or -II and HTLV-III (27% vs 0%), and 73% were seropositive for at least one of the viruses, compared with only 26% of the whites. The increased HTLV-I and -II infection seen in intravenous drug users suggests that once introduced into a population, these viruses may be transmitted by the same routes as HTLV-III. Transmission may have been restricted mainly to blacks in this study because of local drug use practices. (<i>JAMA</i>1986;255:3133-3137)
Contents
Authors: A Von Dem Bussche, R Machida, K Li, G Loevinsohn, A Khander, J Wang, T Wakita, J Wands, J Li, C Pelletier, N Drouin, S Bédard, J Khakoo, N Bruneau, C Honda, M Nakamura, M Tateno, A Sakai, T Shimakami, T Shirasaki, T Yamashita, K Arai, Y Sakai, S Kaneko, C Cirrhosis Nkontchou, J.-P Bastard, M Ziol, M Aout, E Cosson, N Ganne-Carrie, V Grando- Lemaire, D Roulot, J Capeau, J.-C Trinchet, E Vicaut, M Beaugrand, A Niro, A Smedile, A Ippolito, R Ciancio, A Fontana, M Olivero, M Valvano, D Abate, G Gioffreda, M Caviglia, A Rizzetto, R Gupta, S Dhiman, S Kumari, R Rana, A Agarwal, Y Duseja, F Di Bonzo, M Wong, M Wang, T.-H Cong, A.-T Liu, R Yang, P Cong, S.-Z Wu, Y Tang, H Xu, B.-E Wang, S.-J Qiu, Q Gao, Y.-W Li, C.-X Dai, M.-Y Cai, M.-J Ju, J Zhou, B.-H Zhang, J Fan, N Gayet, J Dusetti, J.-P Selves, L Vinel, P Buscail, J Cordelier, Tions Zhang, H Li, Y Wang, W Liu, Q Zhang, X Zhang, B Han, G Zhou
Journal: Journal of Hepatology (2010)